Nimish P Shah's Net Worth

$687 Million

Estimate Recalculated Feb 21, 2024 09:54PM EST

Who is Nimish P Shah?

Nimish P Shah has an estimated net worth of $687 Million. This is based on reported shares across multiple companies, which include KalVista Pharmaceuticals, Inc., Instil Bio, Inc., CONSTELLATION PHARMACEUTICALS INC, Apogee Therapeutics, Inc., Shockwave Medical, Inc., Altimmune, Inc., Unum Therapeutics Inc., Bellerophon Therapeutics, Inc., Tricida, Inc., Vistagen Therapeutics, Inc., and ARCA biopharma, Inc..

SEC CIK

Nimish P Shah's CIK is 0001698082

Past Insider Trading and Trends

2022 was Nimish P Shah's most active year for acquiring shares with 46 total transactions. Nimish P Shah's most active month to acquire stocks was the month of May. 2021 was Nimish P Shah's most active year for disposing of shares, totalling 6 transactions. Nimish P Shah's most active month to dispose stocks was the month of February. 2023 saw Nimish P Shah paying a total of $29,750,000.00 for 1,797,758 shares, this is the most they've acquired in one year. In 2019 Nimish P Shah cashed out on 1,593,847 shares for a total of $14,899,957.25, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

CONSTELLATION PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+11.06%
400K
$34.50
$13,800,000.00
4.02M
Dec 13
Form 3
0
0
No matching records found

Shockwave Medical, Inc. (SWAV) Snapshot price: $235.215

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.12M
2.12M
Mar 11
Form 3
0
0
No matching records found

KalVista Pharmaceuticals, Inc. (KALV) Snapshot price: $14.525

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+1.82%
86.05K
$14.62
$1,257,828.78
4.82M
Feb 6 - Feb 8
Form 4
+1.89%
88.1K
$14.47
$1,274,792.53
4.74M
Jan 30
Form 4
+2.01%
91.8K
$14.05
$1,289,802.42
4.65M
Jan 25 - Jan 29
Form 4
+2.22%
99.13K
$12.53
$1,241,684.52
4.56M
Jan 22 - Jan 24
Form 4
+3.33%
143.6K
$12.55
$1,801,601.80
4.46M
Jan 17 - Jan 19
Form 4
+0.61%
26.25K
$12.72
$333,779.23
4.32M
Jan 11 - Jan 16
Form 4
+3.32%
137.7K
$12.54
$1,726,456.92
4.29M
Jan 8 - Jan 10
Form 4
+1.45%
59.37K
$12.14
$720,543.04
4.15M
Jan 3 - Jan 4
Form 4
+14.52%
519.02K
$12.46
$6,465,649.95
4.09M
Dec 27 - Dec 29
Form 3
0
0
Form 4
-24.46%
-500.00K
$28.75
-$14,375,000.00
1.54M
Mar 18
Form 3
0
0
No matching records found

Altimmune, Inc. (ALT) Snapshot price: $10.445

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-22.22%
-1.00M
3.5M
Feb 25
Form 4
+50.00%
1.5M
$7.54
$11,310,000.00
4.5M
Jun 15
Form 4
+76.85%
1.3M
$8.74
$11,395,493.13
3M
May 26 - May 28
Form 3
0
0
No matching records found

Unum Therapeutics Inc. (COGT) Snapshot price: $5.865

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+11.55%
451K
$2.52
$1,137,120.00
4.36M
Aug 14 - Aug 18
Form 3
0
0
No matching records found